Physician profile
Jonathan Lucking
NPI 1366889545
$1,779.57
in general payments reported to CMS, 2019-2025
12 companies · $113 in 2025
The $113 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $97.72 · 2021: $256 · 2022: $18.75 · 2023: $122 · 2024: $1,172 · 2025: $113.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,050 · Food and Beverage: $357.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,049.69 |
| Food and Beverage | $357.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,126.49 | 2024 | Interstim |
| Intuitive Surgical, INC. | $130.84 | 2021 | |
| Davol INC. | $105.98 | 2023 | Phasix Mesh |
| Olympus America INC. | $97.72 | 2019 | |
| Ethicon US, LLC | $86.78 | 2021 | |
| Integra Lifesciences Corporation | $70.12 | 2025 | Cusa Clarity, Codman Hakim, Duraseal Exact Spinal Sealant System |
| Kerecis Limited | $38.55 | 2021 | |
| Thd America, INC. | $34.87 | 2022-2023 | |
| Daiichi Sankyo INC. | $25.88 | 2024 | Injectafer |
| Abbvie INC. | $22.63 | 2025 | |
| Qol Medical, LLC | $20.50 | 2025 | Sucraid |
| Lilly USA, LLC | $19.21 | 2024 | Omvoh |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Lucking listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.